Skip to content
10-K

Annual Report

Caribou Biosciences, Inc. CRBU

0001619856-25-000015

← back to feed
Filed
Mar 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 4, 2025 93M sh
Shares Diluted FY 2024 · Dec 31, 2023 73.81M sh
Capex FY 2024 · Dec 31, 2023 $11.61M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$93.29M
Cash And Equivalents FY 2024 · Dec 31, 2023 $51.16M
Current Liabilities FY 2024 · Dec 31, 2023 $28.3M
Total Liabilities FY 2024 · Dec 31, 2023 $63.81M
Current Assets FY 2024 · Dec 31, 2023 $338.84M
Total Assets FY 2024 · Dec 31, 2023 $432.21M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.38
Eps Basic FY 2024 · Dec 31, 2023 −$1.38
Sga Expense FY 2024 · Dec 31, 2023 $38.46M
Rd Expense FY 2024 · Dec 31, 2023 $112.08M
Net Income FY 2024 · Dec 31, 2023 −$102.07M
Operating Income FY 2024 · Dec 31, 2023 −$116.06M
Revenue FY 2024 · Dec 31, 2023 $34.48M
Stockholders Equity FY 2024 · Dec 31, 2022 $300.87M